Although previous studies on diabetic nephropathy had the limitation of being restricted to animal experiments, the findings suggest that the circRNA_0001946–miR671-5p–CDR1 axis is a potential therapeutic target for diabetic nephropathy. This evidence concerns the gene CDR1 and diabetic kidney disease.